Back to today’s briefing

Story perspectives

Only 52% Survive Bedaquiline-Resistant TB in South Africa

7/22/2025

50 9

Summary

Story summary

Patients battling bedaquiline-resistant tuberculosis in South Africa face daunting challenges, with recovery times stretching longer and outcomes dimmer compared to those with drug-susceptible strains. In a study of 82 patients, only 52% achieved tuberculosis-free survival after 18 months, underscoring an urgent call for swift resistance testing and enhanced treatment strategies.

1 of 1

Story summary

Patients battling bedaquiline-resistant tuberculosis in South Africa face daunting challenges, with recovery times stretching longer and outcomes dimmer compared to those with drug-susceptible strains. In a study of 82 patients, only 52% achieved tuberculosis-free survival after 18 months, underscoring an urgent call for swift resistance testing and enhanced treatment strategies.